THP-1 macrophage-like differentiation

• Use THP-1 cells, complete cell-culture medium, PMA, and PMA-free fresh medium for the rest phase;
• Reported differentiation conditions include 5 ng/mL PMA for 48 h followed by 24 h rest, 100 nM PMA followed by 5 days rest, 10-200 ng/mL PMA in comparative protocol studies, and 80 ng/mL PMA for 24 h in an optimization study.

• Use antibodies or assays for CD11b, CD14, CD36, CD204, ApoE, MMP9, or α2-macroglobulin when validating macrophage-like differentiation, and use latex bead phagocytosis, LysoTracker, flow cytometry, microscopy, RT-qPCR, ELISA, western blot, or proteomics only when those readouts match the downstream question.

• Use standard cell-culture equipment for sterile mammalian culture, a light or phase-contrast microscope for adherence and morphology, flow cytometry for surface-marker analysis, and optional fluorescence microscopy, ELISA reader, qPCR system, western blot platform, or proteomics workflow for functional or molecular validation.

• Maintain THP-1 cells as suspension monocytes before induction, then seed cells before PMA treatment;
• One optimization study reported 5 × 10^5 cells/mL as part of its optimized condition with 80 ng/mL PMA for 24 h, while other studies used different PMA regimens, so cell density and PMA exposure should be kept constant within a project.

• Prepare PMA-containing medium immediately for the induction condition and prepare PMA-free fresh medium for the rest period; the rest phase is supported because PMA withdrawal after induction improved macrophage-like features in a 5-day rest model and reduced PMA-associated pro-IL-1β bias in a 24-h rest model.

• Seed THP-1 cells in culture vessels suitable for the planned readout and add PMA using one literature-supported regimen: 5 ng/mL for 48 h followed by 24 h rest, 100 nM followed by 5 days rest, or 80 ng/mL for 24 h;
• Avoid changing PMA dose and rest time between experimental groups unless the protocol itself is testing differentiation conditions.

• Incubate cells during PMA exposure until cells become adherent and display macrophage-like morphology;
• After PMA exposure, replace with PMA-free fresh medium and rest cells for the selected literature-supported rest period before stimulation or analysis.

• Validate differentiation before downstream experiments by documenting adherence and morphology and measuring at least one macrophage-associated marker or functional readout reported in the literature, such as CD11b, CD14, CD36, CD204, latex bead phagocytosis, lysosomal signal, ApoE, MMP9, or α2-macroglobulin.

• For inflammatory or infection studies, include an unstimulated differentiated condition and avoid high-PMA protocols when pathogen survival or macrophage viability is central, because high PMA concentrations altered Salmonella interaction and caused rapid death after infection compared with lower-PMA differentiation.

• Interpret successful differentiation as a combined phenotype rather than a single marker: increased adherence and macrophage-like morphology should be paired with marker, functional, or molecular evidence, because THP-1-derived macrophage-like cells can differ from primary human monocyte-derived macrophages and PMA protocols produce different protein and immune-response states.

• Use undifferentiated THP-1 cells as the negative comparison and the same PMA-differentiated protocol across all experimental groups as the internal model control;
• When comparing protocols, analyze differentiation readouts and downstream functional responses separately because PMA concentration and rest duration can independently affect later responses.

Differentiated cells show high basal inflammasome-related IL-1β signal.

Possible Cause:
PMA itself can induce pro-IL-1β and mature IL-1β during differentiation
Literature-supported Solution:
Use 5 ng/mL PMA for 48 h followed by 24 h PMA-free rest before NLRP3-related stimulation or measurement.

Infection experiments show excessive death after bacterial challenge.

Possible Cause:
High-PMA differentiation can make THP-1 macrophages more vulnerable in the Salmonella Typhimurium model
Literature-supported Solution:
Use a lower-PMA differentiation condition when infection survival and intracellular bacterial control are primary readouts.

Results differ between laboratories or batches.

Possible Cause:
PMA dose, exposure time, rest duration, and cell density vary across published THP-1 protocols and alter transcriptomic, proteomic, and immune-response outputs
Literature-supported Solution:
Fix one literature-supported protocol for the whole study and report PMA concentration, exposure time, rest time, cell density, and validation markers.